Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
WP-1302 by Worg Pharmaceuticals Hangzhou for Graves Diseases: Likelihood of Approval
WP-1302 is under clinical development by Worg Pharmaceuticals Hangzhou and currently in Phase II for Graves Diseases. According to GlobalData,...